Recently in Pharma Category

Recently headlines were made as 118 oncologist, of the 22,125 currently active in the United States, sounded the alarm publicly about the rising price of cancer drugs calling them “unsustainable.” This rebellious 118, or half of one percent, appear to be making a valid argument from within a tightly controlled and highly profitable cancer industry. Perhaps unaware to most oncologist and others within the mainstream medical system is that drug companies rely on fraud and half truths to circulate their products. In fact, most major drug companies have repeatedly shown that profit margins trump empathy, true healing and human life 8 days a week.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

While vaccines for mumps, rubella and measles protect those who are vaccinated and prevent them infecting others, new jabs leave a risk of infecting others

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

The following open letter by a PhD Immunologist completely demolishes the current California legislative initiative to remove all vaccine exemptions. That such a draconian and cynical state statute is under consideration in the ‘Golden State’ is as shocking as it is predictable. After all, it was mysteriously written and submitted shortly after the manufactured-in-Disneyland measles ‘outbreak’.


1497679_688807601160188_503807378_n.jpg

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Health Impact News Editor Comments

Dr. MaryAnne Demasi’s documentary on the criminal activity of the pharmaceutical industry regarding cholesterol-lowering statin drugs sent shock waves through the mainstream media in Australia last year. Published in two parts on the popular news show The Catalyst, the pharmaceutical industry complained loudly after the first show, and requested the network not air the second episode, “Heart of the Matter Part 2 – Cholesterol Drug War.”

ABC Australia aired it anyway, but the pharmaceutical influence is apparently too strong, as it was announced that the network would remove the videos from their website because “they breached its impartiality standards.” They also removed them from YouTube.


  • Currently 5/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 5/5 (1 votes cast)

Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities With Contrasting Vaccination Coverage

Sandra Waaijenborg1,3, Susan J. M. Hahné1, Liesbeth Mollema1, Gaby P. Smits2, Guy A. M. Berbers2, Fiona R. M. van der Klis2, Hester E. de Melker1, Jacco Wallinga1


Correspondence: Sandra Waaijenborg, PhD, National Institute of Public Health and the Environment, Centre for Infectious Disease Control, Epidemiology and Surveillance Unit, PO Box 1, 3720 BA Bilthoven, the Netherlands (sandra.waaijenborg@rivm.nl).
Presented in part: European Society for Pediatric Infectious Diseases, The Hague, the Netherlands (poster) June 2011. Partly presented as a poster at the Nordic Vaccine meeting, Copenhagen, 5–7 September 2012.
  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

The global market for cancer drugs has hit $100 billion in annual sales, and could reach $147 billion by 2018, according to a new report by the IMS Institute for Healthcare Informatics, a unit of drug data provider IMS Health.

This figure does not include discounts or rebates paid to insurers and government programs; IMS says that in the case of cancer drugs, this should not make a big difference the overall figure.

1.png

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Why do cancer drugs get such an easy ride?

| | Comments (0)

Rushed approvals result in a poor deal for both patients and cancer research

Unlike most other diseases, cancer instils a special fear and “is treated as an evil, invincible predator, not just a disease.”1 The ability of drug companies to charge very high prices, even when most approved cancer drugs provide little gain for patients, drives much of the research, as desperate patients lead some governments and private insurers to pay whatever companies charge. Officials within the US Food and Drug Administration are enthusiastic about new cancer drugs.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Really Bad Science

| | Comments (0)

1and1.jpg

The media often feeds people misinformation about medical science. Leading the deception are the so-called skeptics who claim to be hard-headed scientists.

One leading promoter of skeptic “science” is the physician Ben Goldacre. I took note of Ben Goldacre when he nominated meta-analysis as his Moment of Genius for the BBC. The BBC were asking people to describe their favorite turning point in the history of science. His choice might be described as Goldacre’s Error. One of the most egregious recent mistakes in medical science, meta-analysis is a sham way of presenting subjective information. Meta-analysis makes it possible to select the available data and get the answer you want. Selecting data is one of the biggest errors a scientist can make.

Let’s use Ben Goldacre’s book Bad Science to show how this works. I consider this book well named – it is very bad science indeed.

Here is an example of how Goldacre misleads by selecting his data. He begins by giving a graph of increased life expectancy in the UK covering the previous century.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Since the swine flu panic that was widespread in 2009, prompting more than 60 million people to get vaccinated against it, countless amounts of individuals – predominantly children – have developed a range of health conditions. Mainly, brain damage has been the issue; everything from sleep disturbances and memory impairments to hallucinations and mental illness have been experienced by those who received the swine flu vaccine.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

CANCER: Nagalase in Blood

| | Comments (0)

Nagalase in Blood

Test for monitoring efficacy of therapy for cancer and certain viral infections

Nagalase in serum / plasma

The test measures the activity of an enzyme α-N-acetylgalactosaminidase (nagalase) in blood.

Nagalase is an extracellular matrix-degrading enzyme that is secreted by cancerous cells in the process of tumor invasion. It is also an intrinsic component of the envelope protein of various virions, such as HIV and the influenza virus. Thus, it is also secreted from virus-infected cells1,3,4.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Health Supreme News

Loading...
Powered by Movable Type 5.13-en

Receive updates

Subscribe to get updates of this site by email:

Enter your Email


Preview | Powered by FeedBlitz

Other sites of ours